Executive investments: Why Teladoc is a winning healthtech business
Executive investments: Why Teladoc is a winning healthtech business
Following its acquisition of multibagger Livongo which deals with diabetes, Teledoc (#TDOC) is now on track to continue a substantially bigger growth path. With its footprint already strongly entrenched in the US, it has now only begun…
Teladoc's move to acquire Livongo is shaking up the health technolog
Teladoc’s move to acquire Livongo is shaking up the health technolog
Photo by Daniel Frank on Pexels.com
Teladoc plans to pay $18.5 billion in cash and stock for Livongo, which provides diabetes monitoring and remote monitoring. The combination of two of the largest publicly-traded virtual care companies announced Wednesday will create a health technology giant just as the demand for virtual care soars.
The two companies combined are said to be worth about…
On Wednesday, The Last Futurist reported on the massive merger between telehealth companies Teladoc and Livongo.
Michael Spencer wrote:
In a sign of the growing importance and value of digital healthcare in the world of medicine, two of the industry’s publicly traded companies have agreed to a significant $18.5 billion merger in mid 2020.
We are of course talking about Teladoc’s purchase of Livongo at $18.5 billion. You can all it a merger but what it is is the accelerated manifestation of digital health companies that will become very powerful.
Teladoc Health is a multinational telemedicine and virtual healthcare company based in the United States and is one of the main winners of the pandemic in health-tech. It’s stock was near $100 at the start of 2020, now it’s double that.
To give you fair scope of the M&A deal, it’s the third-largest deal for a U.S. company this year, behind 7-eleven’s purchase of Speedway gas stations and Analog Devices’ acquisition of Maxim Integrated. As M&A, Chinese IPOs and SPACs all take new relevance this year, the future of digital health is looking brighter in a pandemic and post-pandemic world.
If Zoom calls are the new normal, so is telemedecine. Digital health is not a new concept but one that’s getting mainstream attention now where working, exercising, studying and doing healthcare from home is just really the new normal in many ways.
The merger creates a company that somehow integrates hardware and software to monitor and manage chronic conditions like diabetes, will create a giant in the emerging field of telemedicine and virtual care.
According to Piper Sandler, the combination gives the companies a joint enterprise value of about $37 billion.
It’s a new world and is a good acquisition for Teladoc Health. The new reality of healthcare delivery in the era of COVID-19 rapidly accelerated the adoption of digital and remote care services like those Livongo was selling to its customers.
Healthcare is huge business, something around 15 to 20 percent of the U.S. economy. Think about how behavior has been changing due to the pandemic. Telehealth has been one of the massive growth stories of the Covid-19 era, as patients — particularly in older age groups — avoid clinics and hospitals where they risk exposure to the coronavirus.
So how fast is the sector growing? The combined company is expected to have pro forma revenue of $1.3 billion representing 85% year on year growth, on a pro forma basis. For 2020, the combined company expects adjusted EBITDA to reach $120 million.
Livongo, a provider of coaching services that help people manage chronic conditions, falls in the category of remote health management, which is also seeing soaring demand during the pandemic.
As stocks both companies have been on rocket fuel. Teladoc had tripled in value this year and Livongo was up almost six-fold. Together, they might have a stronger position in an evolving future of healthcare.
It's National #Wellness Month. Come back to check out my daily #encouragement. #qoutes #livongo (at Houston, Texas) https://www.instagram.com/p/B0obD0vFONQ/?igshid=6ieiho2kovkl
A Midwest health system titan emerges, AbbVie buys Allergan, digital health IPOs, and Democrats debate healthcare.
Top weekly #healthcare stories - A Midwest health system titan emerges, AbbVie buys Allergan, digital health IPOs, and Democrats debate healthcare.
Watch out for poop parasites. Seriously.
Healthcare’s Biggest Stories, week of July 1, 2019
Sanford and UnityPoint combine to create a huge Midwest system A 26-state giant.
This week, Sanford and UnityPoint announced their intentionsto merge into a sprawling Midwest nonprofit giant. With the combined entity, the two health systems will boast 76 hospitals across 26 states, $11…